Diabetic Nephropathy

Diabetic nephropathy, also called diabetic kidney disease, is chronic kidney injury caused by diabetes mellitus and is a leading cause of chronic kidney disease and kidney failure worldwide. It classically progresses from glomerular hyperfiltration and increasing albuminuria to declining filtration, with a characteristic glomerular pathology of mesangial expansion, basement-membrane thickening, and nodular glomerulosclerosis.

Definition

Diabetic nephropathy is progressive kidney damage attributable to diabetes mellitus, marked pathologically by mesangial expansion, glomerular basement-membrane thickening, and nodular glomerulosclerosis, and clinically by albuminuria and a progressive decline in glomerular filtration.

Scope

This entry covers diabetic nephropathy as a pathologic process and clinical syndrome: its natural history from albuminuria to falling filtration, its characteristic glomerular lesions, and the metabolic and hemodynamic mechanisms that drive it. It describes how the disease is defined and studied rather than offering management guidance.

Core questions

• How do hyperglycemia and glomerular hemodynamic changes translate into structural kidney injury?
• What is the significance of albuminuria as a marker and risk factor in diabetes?
• Why do some people with diabetes progress to kidney failure while others do not?
• How does diabetic nephropathy relate to overall cardiovascular and mortality risk?

Key concepts

• Glomerular hyperfiltration
• Albuminuria as marker and risk factor
• Mesangial expansion and basement-membrane thickening
• Nodular glomerulosclerosis (Kimmelstiel-Wilson nodules)
• Advanced glycation end products
• Renin-angiotensin system activation
• Inflammation and fibrosis
• Progression to chronic kidney disease and kidney failure

Mechanisms

Chronic hyperglycemia drives diabetic kidney injury through interacting metabolic and hemodynamic pathways. Excess glucose promotes the formation of advanced glycation end products, activation of protein kinase C, and oxidative stress, while glomerular hyperfiltration and intraglomerular hypertension — amplified by the renin-angiotensin system — impose mechanical stress on the filtration barrier. These processes injure podocytes and mesangial cells, thicken the glomerular basement membrane, and expand the mesangial matrix, eventually producing the nodular glomerulosclerosis described by Kimmelstiel and Wilson. Inflammatory cytokines and profibrotic signaling contribute to progressive scarring and tubulointerstitial fibrosis.

Clinical relevance

Diabetic nephropathy is one of the most common causes of chronic kidney disease and kidney failure and is a marker of elevated cardiovascular and mortality risk in people with diabetes. This entry explains the pathology and natural history of the disease and is not a source of diagnostic or treatment recommendations for individual patients.

Epidemiology

Diabetes is a leading cause of chronic kidney disease and end-stage kidney disease in many countries, reflecting the global prevalence of type 2 diabetes. The presence of kidney disease in type 2 diabetes is associated with substantially increased mortality relative to diabetes without kidney involvement.

History

The nodular glomerulosclerosis of diabetes was described by Paul Kimmelstiel and Clifford Wilson in 1936, giving the eponymous Kimmelstiel-Wilson lesion. Later work established albuminuria as an early marker of diabetic kidney disease and articulated the hemodynamic and metabolic mechanisms of progression, and contemporary reviews integrate these into a unified model of diabetic kidney disease.

Debates

Is albuminuria a necessary stage of diabetic kidney disease?

A substantial proportion of people with diabetes lose kidney function without classic progressive albuminuria, challenging the traditional albuminuria-centered staging model and prompting interest in additional markers of injury.

Seminal works

• thomas-2015
• afkarian-2013
• navarro-gonzalez-2008

Frequently asked questions

What is the Kimmelstiel-Wilson lesion?

It is the nodular glomerulosclerosis characteristic of advanced diabetic nephropathy — rounded nodules of accumulated mesangial matrix within the glomerulus — first described by Kimmelstiel and Wilson in 1936.

Why is albuminuria emphasized in diabetic kidney disease?

Increasing albuminuria has historically marked early glomerular injury and predicts progression and cardiovascular risk, although some patients lose filtration without the classic albuminuric course.